Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
IVD Raw Materials Market Size, Value And Growth Trajectory Through 2030
The ivd raw materials market size has experienced significant expansion in recent years. It is projected to grow from $27.47 billion in 2025 to $30.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.8%. The historical growth in this sector is attributed to an increase in clinical diagnostic testing volumes, the rising adoption of immunoassays, the progression of molecular diagnostics, the growing demand for early disease detection, and the proven application of enzymes and antibodies in ivd kits.
The ivd raw materials market is anticipated to experience substantial expansion over the coming years. By 2030, this market is projected to reach $43.76 billion, demonstrating a compound annual growth rate (CAGR) of 9.8%. This projected growth is driven by several factors, including the increasing incidence of chronic and infectious diseases, greater investment in precision diagnostics, the expansion of point-of-care testing, growing biopharmaceutical research and development activities, and a rising need for tailored ivd raw materials. Key trends for the forecast period encompass a growing demand for high-purity diagnostic reagents, increasing adoption of recombinant antibodies and proteins, the broadening application of molecular diagnostics raw materials, a heightened emphasis on quality and batch consistency, and the diversification of supply chains for essential ivd inputs.
Get A Free Sample Report With In-Depth Market Insights:
IVD Raw Materials Market Growth Backed By Core Demand Fundamentals
A growing incidence of infectious diseases is projected to drive the expansion of the IVD raw materials market in the future. These diseases are conditions caused by harmful microorganisms that can transmit from one person or organism to another. The rising occurrence of infectious diseases is attributed to rapid urbanization, which contributes to their spread by increasing population density and straining sanitation and healthcare infrastructure. IVD raw materials are essential in combating infectious diseases by enabling the creation of accurate diagnostic tests for early detection and efficient disease management. For instance, in March 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, the number of tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, indicating an increase of 1,295 cases. Consequently, the expanding prevalence of infectious diseases is fueling the development of the IVD raw materials market.
IVD Raw Materials Market Segment Landscape: Which Areas Lead Development?
The ivd raw materials market covered in this report is segmented –
1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations
Subsegments:
1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies
2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens
3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases
4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins
5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers
IVD Raw Materials Market Growth Trends Reshaping The Competitive Landscape
Major companies operating in the IVD raw materials market are concentrating on developing advanced solutions, such as IVD production facilities, to strengthen regional diagnostic capabilities and support healthcare self-sufficiency. An in vitro diagnostic (IVD) manufacturing facility is a specialized site where devices and equipment used for diagnosing diseases and conditions through laboratory testing of samples outside the human body are designed, produced, and rigorously tested for quality and compliance. For instance, in January 2024, Colexa Biosensor Limited, a Nigeria-based health technology company, partnered with Codix Pharma Limited, a Nigeria-based pharmaceutical manufacturing company, to launch Sub-Saharan Africa’s first in vitro diagnostics (IVD) manufacturing facility in Lagos. This facility, which manufactures the onpoint blood glucose meter and strips, marks a significant milestone in Africa’s healthcare industry, intended to address the growing diabetes prevalence and improve access to diagnostics. The facility has an annual production capacity of 3.6 million packs, with the potential to expand to 10.8 million packs, initially focusing on satisfying the demands of West Africa.
IVD Raw Materials Market Industry Leaders And Competitive Landscape
Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.
View The Full IVD Raw Materials Market Report:
IVD Raw Materials Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the IVD raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ivd raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model









